Akari Therapeutics Plc – Filings and Transcripts

NASDAQ: AKTX
Share price (5/1/26): $5.47
Market cap (5/1/26): $6.261 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

Prospectuses and Registrations Filter

Updated info for already-effective prospectus

Registration of ADRs – amended

Initial registration of new securities

Prospectus supplement for primary offering

Prospectus supplement

Ownership Filter

Prudo-Chlebosz Raymond

Patel Samir Rashmikant

Prudo-Chlebosz Raymond

News Filter

Announces ADS Ratio Change

Shareholder Vote Results

Announces $5 Million Financing, Including Concurrent Registered Direct Offering and Private Placement Priced At-Market

Shareholder Vote Results, Financial Statements or Exhibits

Material Disclosure, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness